Dyne Therapeutics, Inc. - Common Stock, $0.0001 par value per share (DYN)

Historical Holders from Q3 2020 to Q3 2025

Symbol
DYN on Nasdaq
Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
142M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
156M
Holdings value
$1.97B
% of all portfolios
0.006%
Grand Portfolio weight change
+0.001%
Number of holders
204
Number of buys
146
Number of sells
-64
Average Value change %
+0%
Average buys %
+0.003%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Dyne Therapeutics, Inc. - Common Stock, $0.0001 par value per share (DYN)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
JANUS HENDERSON GROUP PLC 10.4% +3% $187M $4.43M 14.7M +2.43% JANUS HENDERSON GROUP PLC 30 Sep 2025
BlackRock, Inc. 5.8% $73.1M 6.58M BlackRock, Inc. 31 Mar 2025
Atlas Venture Fund XI, L.P. 4% $72.3M 5.71M Atlas Venture Associates XI, L.P. 30 Sep 2025
Forbion Capital Fund IV Cooperatief U.A. 4.8% $60M 5.4M ForDyne B.V. 31 Mar 2025
FMR LLC 4.6% -41.3% $57.7M -$31.1M 5.2M -35% FMR LLC 31 Mar 2025
RTW INVESTMENTS, LP 1.5% -72% $18.8M -$39.2M 1.69M -67.6% RTW Investments, LP 31 Mar 2025
Point72 Asset Management, L.P. 1.5% -72% $18.5M -$39.2M 1.67M -67.9% Point72 Asset Management, L.P. 31 Mar 2025

Institutional Holders of Dyne Therapeutics, Inc. - Common Stock, $0.0001 par value per share (DYN)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 156M $1.97B +$382M $12.65 204
2025 Q2 129M $1.22B +$58.2M $9.52 195
2025 Q1 122M $1.28B -$75.9M $10.46 202
2024 Q4 112M $2.63B -$39.5M $23.56 199
2024 Q3 112M $4.03B -$6.35K $35.92 200
2024 Q2 111M $3.92B +$555M $35.29 191
2024 Q1 95.4M $2.71B +$787M $28.39 167
2023 Q4 69.9M $930M +$57.6M $13.30 123
2023 Q3 59.9M $537M +$1.69M $8.96 114
2023 Q2 59.2M $666M +$50.9M $11.25 117
2023 Q1 54.6M $629M +$56.5M $11.52 125
2022 Q4 49.7M $576M +$50.1M $11.59 112
2022 Q3 44.5M $566M -$9.01M $12.70 100
2022 Q2 46.7M $321M -$8.06M $6.87 87
2022 Q1 47.3M $455M -$4.23M $9.64 90
2021 Q4 47.8M $568M +$18.9M $11.89 90
2021 Q3 32.3M $525M -$16.4M $16.24 80
2021 Q2 35.8M $753M +$36.1M $21.04 75
2021 Q1 31.4M $487M +$72.4M $15.53 72
2020 Q4 26.3M $552M +$28.8M $21.00 67
2020 Q3 24.5M $494M +$494M $20.19 49